how long can you take bpc 157 for BPC-157 Peptide Therapy | Regenerative Medicine Peptide Therapy for Pain Management

Adam Cohen is OMRF's senior vice president and general counsel

Its studied for its potential role in recovery from traumatic brain injury and other neurological insults

Please note: This product is strictly for in vitro laboratory research and is not intended for human consumption or veterinary use

It is one of the most widely researched peptides in the compound library used by laboratories studying tissue-related biological pathways

These include: Large disc extrusions or sequestered fragments requiring surgical intervention Severe spinal stenosis with significant canal narrowing Bone spurs (osteophytes) compressing nerve structures Advanced degenerative disc disease with complete disc height loss Spondylolisthesis (vertebral slippage) beyond grade 1 Cauda equina syndrome (medical emergency requiring immediate surgery) Users with these conditions typically report minimal improvement from peptide therapy alone